Baker Avenue Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Baker Avenue Asset Management’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15	Closed	-$587	–	1787
2023 Q1	$587	Hold	15	–	–	﹤0.01%	1358
2022 Q4	$793	Buy	+15	New	+$731	﹤0.01%	1178

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Baker Avenue Asset Management's SILK Position: Q2 2023 in Review

Baker Avenue Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2023, closing a stake of 15 shares — an estimated $587 sold.

Baker Avenue Asset Management first reported a position in SILK in Q4 2022 and held it in 2 quarters. The position peaked at $793 in Q4 2022. 173 funds tracked by Wall St. Rank hold SILK as of Q2 2023.

Baker Avenue Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Baker Avenue Asset Management sold 15 Silk Road Medical, Inc. Common Stock shares in Q2 2023, an estimated $587.
Baker Avenue Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Baker Avenue Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $793 in Q4 2022.
173 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2023.

Based on Baker Avenue Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.